Is Estrella Immunopharma, Inc. (ESLA) a Buy, Sell, or Hold?
NASDAQ : ESLA
Estrella Immunopharma, Inc. — Insider Trades
$0.739 USD
$0.02 (2.28%)
- Volume
- 16.41K
- Average Volume
- 39.19K
- Market Capitalization
- $31.53M
- P/E Ratio
- -2.13
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $3.15
- Year Low
- $0.68
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.24
Insider Activity Summary (Last 12 Months)
Insiders Buying
0
Insiders Selling
0
Amount of Insider Selling
-$
ESLA Insider Buying/Selling by Quarter
ESLA Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Xu Jiandong | officer: Chief Financial Officer | 2025-10-07 | P-Purchase | 1.33 | 2026-04-29 |
| Xu Jiandong | officer: Chief Financial Officer | 2025-09-11 | P-Purchase | 1.04 | 2026-04-29 |
| Xu Jiandong | officer: Chief Financial Officer | 2025-09-22 | P-Purchase | 1.16 | 2026-04-29 |
| Jia Dengyao | director: | 2025-09-22 | 0 | 2025-10-01 | |
| Liu Cheng | director, officer: Chief Executive Officer | 2024-10-30 | A-Award | 0.815 | 2025-02-14 |
| Liu Cheng | director, officer: Chief Executive Officer | 2024-10-30 | A-Award | 0.815 | 2025-02-14 |
| Xu Jiandong | officer: Chief Financial Officer | 2024-10-30 | A-Award | 0.815 | 2025-02-14 |
| Xu Jiandong | officer: Chief Financial Officer | 2024-10-30 | A-Award | 0.815 | 2025-02-14 |
| Zhang Hong | director, other: Chairperson of the Board | 2024-08-14 | 0 | 2024-08-23 | |
| Xu Jiandong | officer: Chief Financial Officer | 2023-09-29 | 0 | 2023-10-10 | |
| Roberts Marsha | director: | 2023-09-29 | 0 | 2023-10-10 | |
| Xu Pei | director: | 2023-09-29 | 0 | 2023-10-10 | |
| Liu Cheng | director, officer: Chief Executive Officer | 2023-09-29 | 0 | 2023-10-10 | |
| Wu Xuejun Janelle | director: | 2023-09-29 | 0 | 2023-10-10 | |
| Wu Fan | director: | 2023-09-29 | 0 | 2023-10-10 | |
| Eureka Therapeutics, Inc. | 10 percent owner | 2023-09-29 | 0 | 2023-10-10 | |
| Eureka Therapeutics, Inc. | 10 percent owner | 2023-09-29 | 0 | 2023-10-10 | |
| Owl Creek Asset Management, L.P. | 10 percent owner | 2023-09-29 | J-Other | 10.86 | 2023-10-05 |
| TradeUP Acquisition Sponsor LLC | 2023-09-29 | 0 | 2023-10-02 | ||
| Long James | 2023-09-29 | 0 | 2023-10-02 | ||
| Jiang Tao | 2023-09-29 | 0 | 2023-10-02 | ||
| Wen Luqi | 2023-09-29 | 0 | 2023-10-02 | ||
| Li Jianwei | 2023-09-29 | 0 | 2023-10-02 | ||
| Twigg Weston | 2023-09-29 | 0 | 2023-10-02 | ||
| Yang Weiguang | 2023-09-29 | 0 | 2023-10-02 | ||
| Owl Creek Asset Management, L.P. | director | 2023-01-05 | 0 | 2023-01-09 | |
| Li Jianwei | officer: Co-Chief Executive Officer | 2022-03-04 | P-Purchase | 314700 | 2022-03-17 |
| Jiang Tao | director | 2021-07-14 | 0 | 2021-07-26 | |
| Twigg Weston | director | 2021-07-14 | 0 | 2021-07-22 | |
| Long James | director | 2021-07-14 | 0 | 2021-07-22 | |
| Yang Weiguang | director, officer: Co-Chief Executive Officer | 2021-07-14 | 0 | 2021-07-22 | |
| TradeUP Acquisition Sponsor LLC | 10 percent owner | 2021-07-14 | 0 | 2021-07-22 | |
| Wen Luqi | officer | 2021-07-14 | 0 | 2021-07-22 | |
| Li Jianwei | director, 10 percent owner, officer: Chairman and Co-CEO | 2021-07-14 | 0 | 2021-07-22 |